Response to Sanver et al.
- Corrado Betterle, MD ,
- Renato Zanchetta, MD and
- Paolo Fabris, MD
- Department of Medical and Surgical Sciences, University of Padua, Padua, Italy
In this issue of Diabetes Care, the letter by Sanver et al. (1) reported previous studies that demonstrated evidence of a correlation among the hepatitis C virus (HCV) antigenic subtypes, prognosis of disease, autoimmune disease development, response to the interferon (IFN)-α treatment, and various immunological responses in the host. In our 70 patients, we carried out the type of HCV …
